North America Breast Implants Market size exceeded USD 630 million in 2021 and is anticipated to expand at 8% CAGR between 2022 and 2028.
Breast cancer is emerging as the most common malignancy among women, a trend highly prevalent in North American countries. According to the American Cancer Society’s estimates, nearly 287,850 new invasive breast cancer cases are expected to be recorded in 2022 in the United States. Since mastectomy is one of the effective breast cancer treatments, breast reconstruction with implants will likely gain massive popularity across the region.
Get more details on this report - Request Free Sample PDF
Another key reason behind the expansion of the breast implants industry across North America is the strong focus on designing cutting-edge medical implant structures via 3D printing. Furthermore, the acceptance of cosmetic surgeries has been on the rise. Such factors, alongside the presence of skilled plastic surgeons, are creating a favorable growth environment for the market players across North America.
The silicone breast implants market in North America is poised to register significant demand during the forecast period, as they used as a preferred product in breast reconstruction and augmentation procedures, given their natural appearance, low risk of downward displacement, and less wrinkling, among other usage advantages.
The adoption of implants for breast reconstruction procedures will increase substantially through 2028, owing to their capability to restore the aesthetic appearance and volume of the breast in breast cancer patients who had undergone mammoplasty.
North American textured breast implant providers will observe commendable business growth since this implant has recently been developed for the reduction and stabilization of capsular contracture. Likewise, the growing prevalence of breast cancer and the popularity of breast reconstruction procedures will also favor the producers of textured breast implants.
The U.S. breast implants market revenue from round shape segment will reach USD 930 million revenue by 2028, credited to the mounting deployment of innovative technologies and well-established healthcare infrastructure in the region. There has also been an upward trend in spending on cosmetic procedures, enabling the regional breast implant producers to expand considerably.
Round breast implants are generally more economical as compared to anatomical or teardrop implants, thus serving as a cost-effective alternative. This type of implant also comes with beneficial attributes such as the creation of ideal breast proportions, which may result in its burgeoning demand among women in North America.
Major players operating in the North America breast implants market include GC Aesthetics, Cereplas, Laboratory Arion, Allergan Plc, Establishment Labs SA, Ideal Implant Inc., Mentor Worldwide LLC, and Sientra.
These companies undertake vital growth strategies like innovative product development to expand their foothold in the market. For instance, in January 2022, Mentor Worldwide LLC gained the U.S. Food and Drug Administration’s approval for iMemoryGel BOOST, a breast implant for women aged at least 22 years undergoing breast augmentation, and women of all ages who are undergoing breast reconstruction. This implant was expected to be commercially available for U.S. surgeons in early 2022.